Skip to content

Single-center Evaluation of Human Milk Quantity and Quality Over Five Years

Evaluation of the Quantity and Quality of Human Breast Milk Collected in a Single-center Milk Bank Over the Last Five Years

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07309146
Acronym
HUMBLE
Enrollment
500
Registered
2025-12-30
Start date
2026-01-01
Completion date
2026-09-30
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lactating Women - Human Milk Donors

Keywords

donor human milk, human milk bank, milk donation, milk volume, milk quality

Brief summary

This single-center retrospective observational study includes all human milk donors collaborating with the milk bank at České Budějovice Hospital between 2021 and 2025. Using anonymized data extracted from the hospital database, the study will quantify the frequency of donations and the individual and cumulative volume of donated human milk and will assess the impact of key maternal and perinatal factors - including age, BMI, parity, mode of delivery, and timing of donations - on the quantity and quality of donated milk, based on routine biochemical and microbiological parameters.

Detailed description

Donor human milk is a key component of nutritional care for preterm and high-risk neonates when mother's own milk is unavailable or insufficient. A better under-standing of which factors are associated with higher or lower donated volumes, and with favorable biochemical and microbiological milk characteristics, may help optimize several aspects of milk bank practice. This study aims to characterize a five-year experience from a single hospital-based human milk bank in terms of donation pat-terns and donated milk volume. It also aims to evaluate the relationship between key maternal and perinatal characteristics and both the quantity and routinely assessed quality of donated human milk.

Interventions

OTHERNo Interventions

Retrospective observational study based on routinely collected clinical and milk bank data; no experimental procedure, treatment, or behavioral intervention is administered.

Sponsors

Charles University, Czech Republic
Lead SponsorOTHER
Nemocnice České Budějovice, České Budějovice, Czechia
CollaboratorUNKNOWN

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Lactating women who donated human milk to the hospital-based human milk bank at České Budějovice Hospital during the period 2021-2025. * Accepted as donors according to local eligibility criteria for human milk donation. * At least one recorded donation of human milk with available data on donation date and volume in the milk bank database. * Availability of basic maternal and perinatal data (e.g., age, BMI, parity, mode of delivery, timing of donation) in the hospital information sys-tem.

Exclusion criteria

* Donors with no recorded volume or date of human milk donation in the milk bank database. * Records with evident data errors or inconsistencies that cannot be reliably corrected (e.g., implausible dates or volumes).

Design outcomes

Primary

MeasureTime frameDescription
Donation intensityAssessed at the end of each donor's donation period (from first to last recorded donation), within January 1, 2021 to December 31, 2025.Donation intensity, defined as the cumulative volume of donated human milk per donor (mL) and the number of donation episodes per donor over the individual donation period within the 5-year study window (2021-2025).

Secondary

MeasureTime frameDescription
Quality of donated human milkAssessed at the end of each donor's donation period (from first to last recorded donation), within January 1, 2021 to December 31, 2025.Quality of donated human milk, assessed by routine biochemical composition parameters and microbiological safety indicators over the individual donation period within the 5-year study window (2021-2025). Biochemical composition parameters: fat (g/L), protein (g/L), carbohydrate (g/L), and calculated energy content (kcal/100 mL) Microbiological safety indicators: total viable bacterial count (CFU/mL) and culture result classified as pass/fail according to the milk bank's routine acceptance criteria

Countries

Czechia

Contacts

CONTACTMarek Petráš, PhD
marek.petras@lf3.cuni.cz00420 26710 2338
CONTACTJiří Dušek, PhD
dusek.jiri@nemcb.cz00420 38 787 5700
STUDY_DIRECTORPavel Dlouhý, PhD

Third Faculty of Medicine, Charles University, Prague, Czech Republic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026